Adage Capital Partners Gp, L.L.C. Moon Lake Immunotherapeutics Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 505,000 shares of MLTX stock, worth $25.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
505,000
Previous 1,825,000
72.33%
Holding current value
$25.8 Million
Previous $80.2 Million
68.27%
% of portfolio
0.05%
Previous 0.15%
Shares
7 transactions
Others Institutions Holding MLTX
# of Institutions
124Shares Held
58.2MCall Options Held
52.2KPut Options Held
38K-
Bvf Inc San Francisco, CA21.8MShares$1.11 Billion34.86% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$435 Million30.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.98MShares$152 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$142 Million2.1% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.32MShares$119 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.89B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...